Clinical Outcomes is a product and service business (within Oxford University Innovation) dedicated to the provision and support of high-quality validated outcomes measures (questionnaires) across the healthcare sector. The vast majority of our measures are Patient Reported Outcome (PRO) Measures (or sometimes referred to as PROMs).
We provide licences for some of the most respected and widely deployed outcome measures used by the pharmaceutical industry, healthcare providers, academia and medical device manufacturers.
The Clinical Outcomes team can also provide expert advice on the development and psychometric validation of new COAs and PROs, as well as the use of our own and other health outcome measures.
Oxford University Innovation's Clinical Outcome team will be attending ISPOR Europe 2024 in Barcelona, Spain from the 17th - 20th November.
Vasculitis is a complex and unpredictable disease, primarily caused by inflammation of the blood vessels.
Oxford University Innovation's Clinical Outcome team will be attending and presenting at the annual ISOQOL 2024 conference in Cologne, Germany from the 13th - 16th October 2024.
